Congratulations to Dr. William Ngo on his publication with colleagues, "LipiFlow for the treatment of dry eye disease" https://t.co/BRw3uj9nUg
RT @PreuvesAcup: 🔶 Médecine fondée sur les preuves 🇺🇸🇨🇦 📰Cochrane Database Syst Rev (IF 𝟵.𝟮) Œil sec et dysfonctionnement des glandes de M…
🔶 Médecine fondée sur les preuves 🇺🇸🇨🇦 📰Cochrane Database Syst Rev (IF 𝟵.𝟮) Œil sec et dysfonctionnement des glandes de Meibomius. Absence d’intérêt du dispositif LipiFlow 𝑣𝑒𝑟𝑠𝑢𝑠 traitements usuels (8 ECR). Aucun ECR 𝑣𝑠 dispositif placebo. https://t.co/l
Bei chronisch trockenen Augen ist die Ursache oft eine Funktionsstörung der Meibomdrüsen. Das #LipiFlow-Gerät soll helfen. Dieser #CochraneReview findet nur schwache Evidenz, dass LipiFlow die Beschwerden ähnlich gut lindert wie andere gängige Mittel. http
RT @CochraneEyes: 🚨JUST PUBLISHED @CochraneLibrary 📚🔍@CochraneEyes #systematicreview asks: What is the effectiveness and safety of Lipiflow…
RT @CochraneEyes: 🚨JUST PUBLISHED @CochraneLibrary 📚🔍@CochraneEyes #systematicreview asks: What is the effectiveness and safety of Lipiflow…
RT @CochraneEyes: 🚨JUST PUBLISHED @CochraneLibrary 📚🔍@CochraneEyes #systematicreview asks: What is the effectiveness and safety of Lipiflow…
🚨JUST PUBLISHED @CochraneLibrary 📚🔍@CochraneEyes #systematicreview asks: What is the effectiveness and safety of Lipiflow compared to other common treatments for dry eye disease in adults? The review found 13 trials with a total of 1155 participants: https